Category Archives: Medical/Health Care

Fikra Labs finalists meet with Under-Secretary of Department of Culture and Tourism-Abu Dhabi

ABU DHABI, Before embarking on their four-week incubation programme, the 12 finalist of the Fikra Labs, an acceleration programme for the travel and tourism industries in Abu Dhabi, met with Saif Saeed Ghobash, Under-Secretary of the Department of Culture and …

سويفت بيوسينسز تطلق لوحات سرطان أكسل أمبليكون بلاس لمبادرات الطب الدقيق

تدفق التسلسل المستهدف الجديد يجمع بين المحتوى المثبت مسبقا والتخصيص السهل وأدوات التحليل الجديدة لتسريع اكتشاف ومسح المتغيرات.

آن آربور، مشيغان، 19 نيسان/أبريل، 2018 / بي آر نيوزواير / — أعلنت شركة سويفت بيوسينسز عن الإطلاق التجاري للوحاتها Accel-Amplicon Plus™

Guggenheim Abu Dhabi to explore work of Sudan’s leading contemporary artist

ABU DHABI, The Guggenheim Abu Dhabi: Talking Art Series returned with its second instalment of 2018 on Wednesday at Louvre Abu Dhabi, exploring the work of one of Sudan’s leading contemporary artists, Ibrahim El-Salahi.

Discussing the importance and significance of …

Romanian President receives UAE delegation participating in 1st UAE-Romanian Joint Committee meeting

BUCHAREST, Romanian President Klaus Iohannis on Tuesday received Dr. Sultan bin Ahmad Sultan Al Jaber, Member of the UAE Cabinet and Minister of State, and his accompanying delegation. The meeting was held on the sidelines of the 1st session of …

American Mission Hospital Receives C3 Summit & PURELIFE “Global Visionary Award”

NEW YORK, April 17, 2018 /PRNewswire/ — In the spirit of the Award, the hospital’s vision and the Summit’s theme, “Moving Healthcare, Commerce and Philanthropy Beyond Bilateral Borders,” Dr. George Cheriyan, CEO and Chief Medical Officer of the American Mission

AstraZeneca Presents Imfinzi (durvalumab) Plus tremelimumab Combination Data at AACR Annual Meeting

Phase Ib Study 006 long-term follow-up shows clinical activity in PD-L1 ≥25% and <25% groups in 2nd-line non-small cell lung cancer

Phase I Study 10 data shows clinical activity with combination treatment in 2nd-line metastatic urothelial carcinoma

CAMBRIDGE, United Kingdom,